Tradestie Institutional Equity Comparison Engine

LLY vs NVO โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

LLY Overall Edge

LLY Captures Institutional Edge (3โ€“1 Pillars ยท 5โ€“5 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Eli Lilly & Co. (LLY) driven by superior Growth & Margin, Momentum & Technical, Options & Structure while NVO counters with relative strength in Valuation. Fundamentally, LLY trades at 28.5x Forward P/E with 51.2% operating margin (+38.6% YoY revenue) versus NVO at 12.2x Forward P/E and 50.8% operating margin (+5.6% YoY). In options structure, LLY sits in BREAKOUT (12th %ile IV; Dealer Gamma Walls on Pro) against NVO sits in CONSOLIDATION (25th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner NVO
LLY 28.5x vs NVO 12.2x Fwd P/E
Growth & Margin Winner LLY
Op Margin 51.2% vs 50.8% ยท YoY +38.6% vs +5.6%
Momentum & Technical Winner LLY
1Y +41.1% vs -15.2% ยท 52W Pos 95% vs 23%
Options & Structure Winner LLY
BREAKOUT (12th %ile IV) vs CONSOLIDATION (25th %ile IV)
LLY NYSE
Eli Lilly & Co.
Pharmaceutical Preparations
$1,443.11
-0.03% 1D
Market Cap $1.27T
1M Return +14.8%
1Y Return +41.08%
Forward P/E 28.5x
Unified AI Score
36.5 / 100 SELL
Tech 20.0 Fund 45.0 Flow 64.0 Mom 40.0
NVO NYSE
Novo-Nordisk A/S
Pharmaceutical Preparations
$41.71
+0.19% 1D
Market Cap $180.7B
1M Return +7.42%
1Y Return -15.15%
Forward P/E 12.2x
Unified AI Score
41.8 / 100 SELL
Tech 56.0 Fund 55.0 Flow 58.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: LLY +41.08% NVO -15.15% Spread: +56.23 pp (LLY Lead)

Pillar 3 Annualized Quarterly Run-Rate Revenue & Operating Margin Trajectory (USD-Normalized)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period LLY Revenue NVO Revenue LLY Op. Margin NVO Op. Margin Margin Edge
Q3 '25 $70.4B $46.3B 47.6% 31.6% LLY
Q4 '25 $77.2B $48.8B 46.6% 40.1% LLY
Q1 '26 $79.2B $59.7B 49.4% 61.6% NVO
Q2 '26 $91.9B $48.4B 54.2% 34.5% LLY
Q3 '26 $97.6B $48.9B 53.7% 29.1% LLY

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: LLY (5) vs NVO (5)
Institutional Metric LLY NVO Criterion Row Winner
Market Capitalization Scale $1.27T $180.7B Larger Scale LLY
Trailing P/E Ratio Valuation 46.3x 10.3x Lower Multiple NVO
Forward P/E Ratio Valuation 28.5x 12.2x Lower Multiple NVO
Revenue Growth (YoY) Growth +38.6% +5.6% Higher Growth LLY
Operating Margin (TTM) Profitability 51.2% 50.8% Higher Margin LLY
Net Profit Margin Profitability 31.9% 33.9% Higher Margin NVO
Return on Equity (ROE) Capital Efficiency 86.0% 58.4% Higher ROE LLY
52-Week Range Position Momentum 95% ($851โ€“$1,475) 23% ($35โ€“$64) Stronger Trend LLY
Beta / 30D Volatility Risk Regime 0.30ฮฒ ยท 37% Vol 0.50ฮฒ ยท 32% Vol Lower Realized Risk NVO
Unified Institutional Score Composite Signal 36.5 / 100 (SELL) 41.8 / 100 (SELL) Higher Composite NVO

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full LLY vs NVO Buy Guide
LLY BREAKOUT
92d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 12th %ile
IV Regime Compressed (<25th %ile)
Live LLY Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
NVO CONSOLIDATION
94d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 25th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live NVO Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither LLY nor NVO registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.